# Review of FEXP_ANON_056

**Overall Score:** **6.2 / 10.0** (Mixed / Salvageable) | **Scientific Core Score:** **5.1 / 8.0**  
* **Score Breakdown:** Rigor: 2.0/3.5 | Claims: 1.5/2.5 | Biology: 1.6/2.0 | Reproducibility: 1.1/2.0

---

## 1. Blinded Metadata Perception

* **Perceived Field & Subfield:** Clinical Oncology Nutrition / Cancer Cachexia / Longitudinal Gut Microbiome Biomarkers
* **Study Design:** Prospective single-center observational cohort study profiling fecal V4 16S rRNA microbiota at baseline (V1) and after ~6 weeks of multidisciplinary individualized nutritional counseling (V2) to identify microbial predictors of weight maintenance/gain versus continued weight loss.
* **Model System & Sample Size:** Human patients with cancer cachexia/weight loss attending the McGill Cancer Nutrition-Rehabilitation Program (`CNR-JGH`; 280 screened, 121 consented, 93 donated V1 stool, $N = 38$ retained with paired V1–V2 stool samples; stratified into Weight Stable/Gain [WSG, $N = 29$: 19 weight gain + 10 weight stable] vs. Weight Loss [WL, $N = 8$], plus 1 unweighed patient; supplemented by 14 V1-only participants for a combined baseline sensitivity analysis of $N = 52$ [38 WSG vs. 13 WL]).
* **Perceived Methodological Maturity:** Strong clinical phenotyping (DXA appendicular lean mass, 24-h dietary recalls, HEI-2015, mGPS, WLGS), exceptional wet-lab batch quality control (64 homogenized healthy donor stool extraction aliquots run across batches), and appropriate compositional differential abundance testing (`ANCOM-BC` with Holm–Bonferroni correction); weakened by severe attrition/survivorship bias ($45/93$ V1 participants lost before V2), a very small and heterogeneous WL subgroup ($N = 8$), post-hoc threshold selection with base-rate neglect in the "conditional probability analysis," and absence of a public sequence repository accession.

---

## 2. Executive Summary & Editorial Verdict

This prospective cohort study investigates whether baseline (V1) and longitudinal (V2, ~6 weeks) fecal V4 16S rRNA microbiome features predict weight response to individualized dietitian-led nutritional counseling in patients with cancer cachexia at the McGill Cancer Nutrition-Rehabilitation clinic (`CNR-JGH`). Of 93 patients who provided a V1 stool sample, 38 provided valid paired V1–V2 stool samples within 2 weeks of clinic visits and passed sequencing quality control (which included 64 Longitudinal DNA extraction control aliquots from a single homogenized healthy donor stool). Between V1 and V2, mean energy intake increased from $26 \pm 10$ to $30 \pm 12\text{ kcal/kg/day}$ ($p = 0.003$) and protein intake increased from $1.1 \pm 0.4$ to $1.4 \pm 0.6\text{ g/kg/day}$ ($p < 0.001$); 29 patients maintained or gained weight ($\text{WSG}: +1.5 \pm 1.4\text{ kg}$) while 8 lost weight ($\text{WL}: -2.9 \pm 1.3\text{ kg}$). At baseline (V1), group-level alpha diversity did not differ significantly between WSG and WL (Faith PD $p = 0.14$), but `ANCOM-BC` (Holm–Bonferroni adjusted $p = 0.014$) identified lower baseline *Lachnospira* genus abundance in the WL group ($\log\text{FC} = -2.8$, $95\%\text{ CI } [-2.0, -3.6]$), a finding corroborated when adding 14 V1-only patients ($N = 52$, adjusted $p = 0.03$). At V2, the WL group exhibited lower Faith PD ($p = 0.05$) and Observed OTUs ($p = 0.046$) and higher paired V1–V2 Jaccard dissimilarity ($p = 0.01$).

**Editorial Verdict: Major Revision (Mixed / Salvageable).** The study addresses an important clinical problem, features thorough nutritional and body composition phenotyping (DXA, ASA24/HEI-2015, mGPS, WLGS), implements an exemplary 64-aliquot wet-lab extraction control protocol that caught and excluded two drifted runs, and uses a rigorous compositional method (`ANCOM-BC` with Holm–Bonferroni adjustment) to identify baseline *Lachnospira* depletion, which replicates in the expanded $N = 52$ baseline cohort. However, several statistical and reporting flaws need correction:
1. **Post-Hoc Cutoff Selection and Base-Rate Neglect in "Conditional Probability Analysis":** Although baseline alpha diversity did not differ significantly between WSG and WL ($p = 0.14$, Figure 2A), the Abstract and Results claim that *"Greater alpha-diversity... at baseline predicted higher likelihood that patients would have good response"* based on a post-hoc cutoff of $\text{Faith PD} > 15$ yielding an 86% probability of WSG vs. 74% when $\text{Faith PD} \le 15$ (line 226). Because the unconditional prior probability (base rate) of WSG in the cohort is already $29/37 = \mathbf{78.4\%}$, an 86% vs. 74% split across 37 patients is completely indistinguishable from chance (Fisher's exact $p > 0.60$). Presenting non-significant post-hoc threshold splits as predictive biomarkers in the Abstract is statistically invalid.
2. **Severe Attrition/Survivorship Bias and Unadjusted Clinical Heterogeneity:** Nearly half ($45/93 = 48.4\%$) of V1 stool donors did not provide a V2 sample, including 7 who died and 16 who dropped out due to clinical debility (line 137). In the remaining paired cohort, the WL group has only $N = 8$ patients across mixed primary tumor types (38% GI vs. 17% in WSG, 0% lung vs. 17% in WSG, 50% $\ge 2\text{nd}$-line therapy vs. 31% in WSG; Table 1).
3. **Missing Public Repository Accession for 16S Sequencing Reads:** No NCBI SRA, ENA, or GSA accession number is provided for the 16S rRNA dataset.

### Specific Conclusions and Assessment of Support

* **Baseline *Lachnospira* genus abundance is significantly lower in cachectic patients who subsequently lose weight despite nutritional counseling: [Moderately Supported].**  
  Tested via `ANCOM-BC` with Holm–Bonferroni multiple testing correction across 55 genera (prevalence-filtered at 10%), *Lachnospira* is significantly lower at V1 in WL vs. WSG in both the paired cohort ($N = 37$, adjusted $p = 0.014$) and the expanded cohort including 14 V1-only patients ($N = 51$ with weight data, adjusted $p = 0.03$). However, the small number of WL events ($N = 8$ paired, $N = 13$ expanded) and heterogeneity in primary tumor site (GI vs. non-GI) warrant caution.

* **Greater baseline alpha diversity ($\text{Faith PD} > 15$) predicts a higher likelihood of positive weight response (WSG) to nutritional intervention: [Overstated].**  
  Group-level baseline Faith PD is not statistically significant ($p = 0.14$, Figure 2A). Dichotomizing at an arbitrary post-hoc threshold ($\text{Faith PD} > 15$) yields 86% WSG above the threshold vs. 74% WSG below the threshold—a trivial deviation from the 78.4% ($29/37$) cohort base rate that fails Fisher's exact test.

* **Patients who lose weight (WL) develop a less diverse and less stable gut microbiome at V2 compared to patients who maintain or gain weight (WSG): [Fragile].**  
  While V1–V2 Jaccard dissimilarity is higher in WL ($p = 0.01$, Figure 3B), V2 Faith PD ($p = 0.05$) and the number of "top changing sequences" ($p = 0.05$, defined by an arbitrary raw count change $> 500$) are borderline, and Figure S3 explicitly shows that the longitudinal *change* in alpha diversity ($\text{V2} - \text{V1}$) does not differ between WSG and WL ($-0.07$ vs. $-0.6$, $p = 0.80$).

* **Multidisciplinary nutritional counseling at CNR-JGH significantly increases energy and protein intake in patients with cancer cachexia: [Well Supported].**  
  Paired dietary assessments demonstrate significant increases in mean energy intake ($26$ to $30\text{ kcal/kg/day}$, $p = 0.003$) and protein intake ($1.1$ to $1.4\text{ g/kg/day}$, $p < 0.001$) across the cohort, with similar intake gains in both WSG and WL groups (Table 3).

---

## 3. Forensic Defect Inventory

### 1. Post-Hoc Threshold Selection and Base-Rate Neglect in Conditional Probability Claims (Pillars 1, 3, 4)
* **Defect:** Despite finding no group-level difference in V1 alpha diversity ($p = 0.14$, Figure 2A), the authors select post-hoc cutoffs (`Faith PD > 15` and `Lachnospira counts > 50`, lines 226–232) and report conditional probabilities $\text{P}(\text{WSG} \mid \text{Faith PD} > 15) = 86\%$ versus $\text{P}(\text{WSG} \mid \text{Faith PD} \le 15) = 74\%$ without comparing against the prior probability $\text{P}(\text{WSG}) = 29/37 = 78.4\%$ or reporting a $p$-value or ROC AUC with cross-validation.
* **WHY:** When 78.4% of the sample belongs to the positive class (WSG), any random split of the data will yield conditional probabilities hovering around 75–85%. Claiming in the Abstract that *"Greater alpha-diversity... at baseline predicted higher likelihood that patients would have good response"* when $p = 0.14$ misleads readers into believing baseline alpha diversity is a statistically significant predictor.
* **WHAT:** Remove the claim that baseline alpha diversity predicts weight response from the Abstract and Conclusion, and replace the unvalidated conditional probability table (Figure 2D) with a formal receiver operating characteristic (ROC) curve, area under the curve (AUC) with 95% DeLong/bootstrap confidence intervals, and leave-one-out cross-validated (LOOCV) sensitivity/specificity for *Lachnospira* relative abundance.
* **HOW:** Compute the ROC AUC for baseline *Lachnospira* (and Faith PD) predicting WSG vs. WL across both the $N = 37$ paired cohort and the $N = 51$ expanded cohort in R (`pROC::roc`), report the exact Fisher's exact test $p$-values for any contingency table cutoffs, and revise the Abstract accordingly.

### 2. Attrition Bias Analysis and Normalization of ASV Count Stability Metrics (Pillars 2, 3, 4)
* **Defect:** (a) Of 93 patients who donated V1 stool, 45 dropped out before V2 (including 7 deaths and 16 withdrawals for debility; line 137), and 14 of these V1-only patients had recorded V2 weight changes (line 230: 5 WL and 9 WSG, bringing the total from $8$ WL / $29$ WSG to $13$ WL / $38$ WSG; note also that $13 + 38 = 51$, whereas line 230 says *"total 52 participants: 13 WL vs. 38 WSG"* because the 1 unweighed patient is included in the total). (b) Section "Global Changes in Detected ASV" (line 104) defines unstable ASVs using a raw threshold of `count change > 500` between V1 and V2, without clarifying whether counts were rarefied to 18,000 reads per sample prior to computing differences.
* **WHY:** If `count change > 500` and `Lachnospira counts > 50` were computed on unrarefied sequencing libraries, variations in library sequencing depth directly bias the count thresholds. Furthermore, the concordance rule defined in Methods line 121 (*"requiring a minimum of two out of the four diversity metrics to be statistically significant for an overall difference in diversity to be declared"*) was not satisfied at V2 after Benjamini–Hochberg correction (since Faith PD had nominal $p = 0.05$ and Observed OTUs had nominal $p = 0.046$, while Shannon and Pielou's Evenness were non-significant; line 239).
* **WHAT & HOW:** Explicitly confirm whether ASV counts in Figures 2B–D and 3C were rarefied to 18,000 reads (or convert them to relative abundances / centered log-ratio [CLR] values); apply the pre-specified Benjamini–Hochberg correction (Methods line 121) across the four alpha-diversity metrics at V2 and state clearly whether V2 alpha diversity passes the two-of-four FDR-adjusted concordance threshold; and compare baseline V1 clinical/microbiome characteristics of the 45 dropouts against the 38 retained participants to quantify attrition bias.

### 3. Missing Public Repository Accession and Table 2 / Text Typographical Fixes (Pillar 7)
* **Defect:**
  1. **Missing Data Availability Accession:** No public repository accession (e.g., NCBI SRA or ENA) is provided for the 16S rRNA amplicon dataset.
  2. **Table 2 (line 186):** The standard deviation of 6-week pre-V1 weight change in the WSG group is printed as a negative number: `-0.8 (-2.8)` instead of `-0.8 (2.8)`.
  3. **Table 2 (line 194):** The row `Dietary quality score | N (%) | V1 | 56 (14%) | 55 (15%) | 58 (10%)` mislabels the continuous `Mean (SD)` of the HEI-2015 score ($56 \pm 14$, as confirmed in the text on line 216) as `N (%)` with percent signs.
  4. **Line 99:** Writes `Shannon (Observed OTU's)`—merging two distinct metrics (Shannon index and Observed OTUs/ASVs) into a single phrase so only three metrics are listed instead of four.
  5. **Line 198:** Writes `eating a poor (< 25 kcal/day) diet` instead of `< 25 kcal/kg/day`.
  6. **Line 230:** Writes `total 52 participants: 13 WL vs. 38 WSG` ($13 + 38 = 51$; the 52nd participant had missing weight change data).
* **WHY:** Missing sequence accessions prevent independent bioinformatic verification, and negative standard deviations or mislabeled units in summary tables impair readability.
* **WHAT & HOW:** Deposit the de-identified 16S rRNA FASTQ files and sample metadata in NCBI SRA or ENA and add a Data Availability Statement; fix `-0.8 (-2.8)` to `-0.8 (2.8)` and `N (%)` / `%` to `Mean (SD)` in Table 2; separate `Shannon index, Observed ASVs` on line 99; change `< 25 kcal/day` to `< 25 kcal/kg/day` on line 198; and clarify $13 + 38 = 51$ (plus 1 unweighed participant = 52) on line 230.

---

## 4. Quantitative Rubric Scoring

| Rubric Dimension | Score | Max | Forensic Justification |
| :--- | :---: | :---: | :--- |
| **1. Methodological & Statistical Rigor** | **2.0** | **3.5** | Rigorous 64-aliquot wet-lab extraction quality control and appropriate `ANCOM-BC` Holm–Bonferroni testing at V1 ($N=37$ and $N=51$), but flawed post-hoc "conditional probability" cutoffs ignoring the 78.4% base rate, very small WL sample size ($N=8$), and nominal $p=0.05$ at V2 failing the pre-specified BH-adjusted 2-of-4 concordance rule. |
| **2. Claim-to-Evidence Alignment** | **1.5** | **2.5** | Abstract and text overstate baseline alpha diversity as a predictor of positive weight response despite group-level $p = 0.14$, and claim reduced diversity at V2 despite longitudinal $\Delta\text{Faith PD}$ showing $p = 0.80$ (Figure S3); Discussion candidly acknowledges limitations of the small heterogeneous cohort. |
| **3. Data Integrity & Biological Plausibility** | **1.6** | **2.0** | High-quality clinical, dietary (24-h recall, HEI-2015), and body composition (DXA ALM) phenotyping; 48% attrition between V1 and V2 (including deaths and debility) introduces survivorship bias that is transparently documented in the PRISMA flow diagram and text. |
| **4. Reproducibility & Data Integrity** | **1.1** | **2.0** | No public sequence repository accession (SRA/ENA) provided for the 16S rRNA sequencing data; minor numerical/unit typos in Table 2 (negative SD `-2.8`, HEI-2015 Mean/SD mislabeled as `N (%)`), line 99, line 198, and line 230 ($13 + 38 = 51 \ne 52$). |
| **Scientific Core Score** | **5.1** | **8.0** | Sum of Rigor (2.0) + Claims (1.5) + Biology (1.6). |
| **Overall Composite Score** | **6.2** | **10.0** | **Mixed / Salvageable Tier** (Sum of all four dimensions). |
